International Journal of Women's Health (Dec 2022)

Management of Premenstrual Dysphoric Disorder: A Scoping Review

  • Carlini SV,
  • Lanza di Scalea T,
  • McNally ST,
  • Lester J,
  • Deligiannidis KM

Journal volume & issue
Vol. Volume 14
pp. 1783 – 1801

Abstract

Read online

Sara V Carlini,1 Teresa Lanza di Scalea,2 Stephanie Trentacoste McNally,3 Janice Lester,4 Kristina M Deligiannidis5 1Department of Psychiatry, Maimonides Medical Center, Brooklyn, NY, USA; 2Departments of Psychiatry & Behavioral Sciences and Women’s Health, Dell Medical School, University of Texas at Austin, Austin, TX, USA; 3Department of Obstetrics and Gynecology, Katz Institute for Women’s Health, Queens, NY, USA; 4Health Science Library, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA; 5Departments of Psychiatry, Molecular Medicine, and Obstetrics & Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USACorrespondence: Kristina M Deligiannidis, Women’s Behavioral Health, Zucker Hillside Hospital, Northwell Health, 75-59 263rd Street, Glen Oaks, NY, 11004, USA, Tel +1-1-718-470-8184, Fax +1-1 718-343-1659, Email [email protected]: Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. The present work is a clinically focused scoping review of the last twenty years of research on treatment for these disorders. A search of key terms using the PubMed/Medline, the Cochrane Library, Embase, and Web of Science databases was performed, and 194 studies of adult women met initial inclusion criteria for review. Research studies concerning medications, pharmacological and non-pharmacological complementary and alternative medicine treatments, and surgical interventions with the most available evidence were appraised and summarized. The most high-quality evidence can be found for the use of selective serotonin reuptake inhibitors (SSRIs) and combined oral contraceptives (COCs), with gonadotropin releasing hormone (GnRH) agonists and surgical interventions showing efficacy for refractory cases. While there is some evidence of the efficacy of alternative and complementary medicine treatments such as nutraceuticals, acupuncture, and yoga, variability in quality and methods of studies must be taken into account.Keywords: premenstrual syndrome, syndrome, dysphoria, dysphoric disorder, disorder, disorders, treatment, scoping, review

Keywords